You are here

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
TIGIT is a key inhibitory checkpoint receptor in lymphoma

 

Online download statistics by month:

Online download statistics by month: June 2023 to February 2026

AbstractFullPdf
Jun 202326226337
Jul 2023388395115
Aug 202323323676
Sep 202312712736
Oct 202314615161
Nov 202312812948
Dec 2023818238
Jan 2024939363
Feb 2024727233
Mar 2024868890
Apr 202410610643
May 2024727349
Jun 202410610538
Jul 202416316736
Aug 202410810772
Sep 2024105109158
Oct 2024929441
Nov 2024919218
Dec 2024666725
Jan 2025777722
Feb 2025666634
Mar 2025616127
Apr 2025838936
May 2025515329
Jun 2025495126
Jul 2025110
Feb 2026110
Total291429551251